Clinical Immunotherapeutics

, Volume 2, Issue 3, pp 161–166 | Cite as

Stem Cell Factor

Biological Actions and Potential Role in Therapy
  • Michael S. Gordon
Leading Article


Stem cell factor (SCF) is the ligand for the proto-oncogene c-kit. As a single agent it has only weak stimulatory effects on haemopoietic cells. However, when administered in combination with other haemopoietic growth factors it has the ability to stimulate the proliferation of committed as well as primitive haemopoietic cells.

A phase I/II study has explored the ability of SCF plus granulocyte colony-stimulating factor (G-CSF) to mobilise peripheral blood progenitor cells for reinfusion after high dosage chemotherapy. The combination of SCF plus G-CSF resulted in a 2-fold greater increase in the peripheral white blood cell count compared with G-CSF alone, as well as increases in granulocyte-macrophage colony-forming cells and CD34+ cells. There was a trend to accelerated platelet recovery following reinfusion of cells mobilised with SCF plus G-CSF compared with G-CSF alone.

Additional studies are required to define further the roles of SCF in the mobilisation of peripheral blood progenitor cells and in other potential therapeutic areas, such as treatment of bone marrow failure or HIV infection.


Stem Cell Factor Bone Marrow Failure Peripheral Blood CD34 Peripheral Blood Progenitor Cell Haemopoietic Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Williams D, Eisenman J, Baird A, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990; 63: 167–74PubMedCrossRefGoogle Scholar
  2. 2.
    Zsebo K, Wypych J, McNiece I, et al. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 1990; 63: 195–201PubMedCrossRefGoogle Scholar
  3. 3.
    Huang E, Nocka K, Beier D, et al. The hematopoietic growth factor KL is encoded at the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990; 63: 225–33PubMedCrossRefGoogle Scholar
  4. 4.
    Russell E. Hereditary anemias of the mouse: a review for the geneticist. Adv Genet 1979; 20: 357–459PubMedCrossRefGoogle Scholar
  5. 5.
    Broudy V, Smith F, Lin N, et al. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 1992; 80: 60PubMedGoogle Scholar
  6. 6.
    Pietsch T, Kya U, Steffens E, et al. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1992; 80: 1199–206PubMedGoogle Scholar
  7. 7.
    Strohmeyer T, Peter S, Hartmann M, et al. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 1991; 51: 1811–6PubMedGoogle Scholar
  8. 8.
    Bernstein I, Andrews R, Zsebo K. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin-cells, and the generation of colony-forming cell progeny from CD34+lin-cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 2316–21PubMedGoogle Scholar
  9. 9.
    McNiece I, Langley K, Zsebo K. Recombinant human stem cell factor synergises with CSFs and epo to stimulate colony formation of myeloid and erythroid cells [abstract]. Blood 1990; 76 (10 Suppl. 1): 606aGoogle Scholar
  10. 10.
    Srour E, Brandt J, Briddell R, et al. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 1993; 81: 661–9PubMedGoogle Scholar
  11. 11.
    Haylock D, To L, Dowse T, et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992; 80: 1405–12PubMedGoogle Scholar
  12. 12.
    Ulrich T, del Castillo J, Yi E, et al. Hematologic effects of stem cell factor in vivo and in vitro in rodents. Blood 1991; 78: 645–50Google Scholar
  13. 13.
    Molineux A, Migdalska A, Szmitkowski M, et al. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered to mice whether alone or in combination with granulocyte colony-stimulating factor. Blood 1991; 78: 961–6PubMedGoogle Scholar
  14. 14.
    Schuening F, Appelbaum F, Deeg H, et al. Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1993; 81: 20–6PubMedGoogle Scholar
  15. 15.
    Andrews R, Bartelmez S, Egrie J, et al. Recombinant human stem cell factor stimulates in vitro and in vivo hematopoiesis in baboons [abstract]. Blood 1990; 76 (10 Suppl. 1): 509aGoogle Scholar
  16. 16.
    Andrews R, Bensinger W, Knitter G, et al. The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 1992; 80: 2715–20PubMedGoogle Scholar
  17. 17.
    Briddell RA, Hartley CA, Smith KA, et al. Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 1993; 82: 1720PubMedGoogle Scholar
  18. 18.
    Andrews R, Briddell R, Knitter G, et al. Low dose recombinant human stem cell factor has a synergistic interaction with recombinant human granulocyte colony-stimulating factor in vivo for stimulating the circulation of progenitor cells of multiple types in the peripheral blood of baboons [abstract]. Blood 1993; 82: 913aGoogle Scholar
  19. 19.
    Crawford J, Lau D, Erwin R, et al. A phase I trial of recombinant methionyl human stem cell factor in patients with non-small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1993; 12: 338aGoogle Scholar
  20. 20.
    Demetri G, Costa J, Hayes D, et al. A phase I trial of recombinant methionyl human stem cell factor in patients with advanced breast carcinoma pre- and post-chemotherapy with cyclophosphamide and doxorubicin [abstract]. Proc Am Soc Clin Oncol 1993; 12: 367aGoogle Scholar
  21. 21.
    Orazi A, Gordon M, Neiman R, et al. Bone marrow effects of recombinant methionyl human stem cell factor (SCF) in patients with normal hematopoiesis [abstract]. Proc Am Assoc Cancer Res 1993; 34: 2777aGoogle Scholar
  22. 22.
    Tong J, Gordon M, Srour E, et al. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 1993; 82: 784–91PubMedGoogle Scholar
  23. 23.
    Demetri G, Gordon M, Hoffman R, et al. Effects of recombinant methionyl human stem cell factor on hematopoietic progenitor cells in vivo: preliminary results of a phase I trial [abstract]. Proc Am Assoc Cancer Res 1993; 34: 1295aGoogle Scholar
  24. 24.
    McNiece I, Glasby J, LeMaistre F, et al. Effects of recombinant methionyl human stem cell factor (rhSCF) and filgrastim (rhG-CSF) on mobilization of peripheral blood progenitor cells: preliminary laboratory results from a phase I/II study [abstract]. Blood 1993; 82 (10 Suppl. 1): 325aGoogle Scholar
  25. 25.
    Alter B, Knobloch M, He L, et al. Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure states. Blood 1992; 80: 3000–8PubMedGoogle Scholar
  26. 26.
    Miles S, Lee K, Hutlin L, et al. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Blood 1991; 78: 3200–8PubMedGoogle Scholar
  27. 27.
    Luskey BD, Rosenblatt M, Zsebo K, et al. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 1992; 80: 396–402PubMedGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Michael S. Gordon
    • 1
  1. 1.Clinical Hematology and Cytokine Program Section of Hematology/OncologyIndiana University School of MedicineaIndianapolisUSA

Personalised recommendations